##  [Clinical Equipoise](/clinical-equipoise-0) 

 Definition

Ethical condition for initiating and continuing randomized clinical trials defined as a genuine, reasonable uncertainty within the relevant clinical expert community about the comparative therapeutic merits of the trial arms, such that no arm is known to be inferior at the time of enrolment.

 

 

 

 

 

 





## Principle

Principle

A randomized trial is ethically defensible only while honest expert disagreement persists about which intervention is superior; once convincing evidence establishes superiority for one arm, continuing to randomize without modification becomes ethically problematic.

 

 

 

 

 





## Demonstration

Demonstration

Illustrative scenario: Situation — Two standard treatments A and B are in widespread use and experts disagree about which yields better long‑term outcomes. Recognition — Investigators and clinical leaders document that the community lacks conclusive comparative evidence. Action — A randomized trial comparing A and B is launched with independent monitoring and prespecified stopping rules. Consequence — Enrollment proceeds while uncertainty persists; if interim analyses show clear superiority of one arm, the trial is stopped or redesigned to prevent exposing participants to inferiority.

 

 

 

 

## Misapplication

Misapplication

Confusing individual clinician uncertainty (personal equipoise) with clinical equipoise is an error: individual belief differences do not by themselves justify a trial unless the broader expert community also lacks convincing comparative evidence.

 

 

 

 

 





## Consequence

Consequence

Clinical equipoise legitimizes randomization in trials that answer genuine unanswered clinical questions, influences trial design (choice of comparators, use of standard care arms, stopping rules), and requires ongoing review of accumulating evidence to protect participants.

 

 

 

 

## Reversal

Reversal

Equipoise may be lost when high‑quality external evidence emerges, when subgroup analyses convincingly favor one treatment for particular patients, or when a data safety monitoring board determines that continuing randomization would expose participants to undue risk; under those conditions trials must be altered, paused or stopped.

 

 

 

 

 





## Boundary

Boundary

Applies to clinical research that would randomize patients between competing therapeutic strategies; it does not govern purely observational studies and differs from ethical requirements for research consent, which are distinct protections for participant autonomy and welfare.

 

 

 

 

 





## Semantic Tension

Semantic Tension

Tension with Therapeutic Obligation to Individual Patients: clinicians have duties to individual patients while researchers seek generalizable knowledge; equipoise aims to reconcile this by ensuring trials address unresolved community questions rather than knowingly offering inferior care.

 

 

 

 

 





## Synthesis

Synthesis

Clinical equipoise protects research participants by tethering the ethical permissibility of randomization to genuine communal uncertainty; it requires that trialists continuously monitor evidence and adapt or cease randomization when uncertainty resolves.